Abstract
Purpose
Exploring a possible link between upper airway inflammation and the development of cholesteatoma by studying the association between mucosa-affecting diseases of the upper airways and cholesteatoma surgery.
Methods
This is a nationwide case–control study of 10,618 patients who underwent surgery for cholesteatoma in Sweden between 1987 and 2018. The cases were identified in the National Patient Register and 21,235 controls matched by age, sex and place of residency were included from national population registers. Odds ratios (OR) and corresponding 95% confidence intervals were used to assess the association between six types of mucosa-affecting diseases of the upper airways and cholesteatoma surgery.
Results
Chronic rhinitis, chronic sinusitis and nasal polyposis were more common in cholesteatoma patients than in controls (OR 1.5 to 2.5) as were both adenoid and tonsil surgery (OR > 4) where the strongest association was seen for adenoid surgery. No association was seen between allergic rhinitis and cholesteatoma.
Conclusion
This study supports an association between mucosa-affecting diseases of the upper airways and cholesteatoma. Future studies should aim to investigate the mechanisms connecting mucosa-affecting diseases of the upper airways and cholesteatoma formation regarding genetic, anatomical, inflammatory and mucosa properties.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
The mucosa lining the tympanic cavity is continuous with the Eustachian tube, the nasopharynx, and the mastoid [1]. An association between chronic rhinosinusitis (CRS) and chronic otitis media (COM), a chronic inflammation of the middle ear, has been reported [2]. It can potentially be explained by the anatomical proximity through the Eustachian tube or by immunologic similarities of the mucosa [2, 3]. Eustachian tube dysfunction has also been shown to be associated with allergic rhinitis [4].
Cholesteatoma of the middle ear is a mass consisting of keratinizing squamous epithelium growing in the tympanic cavity and/or the mastoid [5]. The annual incidence of cholesteatoma ranges from 9 to 15 per 100 000 people, with a male preponderance [6]. Serious complications such as deafness, facial palsy, and intracranial infections occur and surgical treatment is, therefore, recommended [7]. The pathophysiology of cholesteatoma is relatively unknown and many biomolecular hypotheses have been suggested [8]. One theory is that cholesteatoma arises due to Eustachian tube dysfunction [7]. Another theory is that it may be the result of a reaction of the eardrum with an inflammatory dysregulation including immune cells and cytokines in the middle ear, that can be triggered by infection [9].
An association between CRS and cholesteatoma has previously been reported [3, 10]. One of the studies also showed an association between allergic rhinitis and cholesteatoma [10]. Another study showed positive associations between both CRS and nasal polyposis with cholesteatoma but a negative association between allergic rhinitis and cholesteatoma, partially contradicting the other studies [11]. To the best of our knowledge there is only one previous study investigating the association between allergy and cholesteatoma in a European setting [12]. Causes of adenoid and tonsil hypertrophy are insufficiently known, but it has been shown that recurrent infections, allergies, gastric reflux, and passive smoking are risk factors [13]. It has also been shown that adenoid hypertrophy may contribute to the cause of CRS [13].
The anatomically connected mucosa, the observed associations between CRS and chronic otitis media, as well as the association between allergies and Eustachian tube dysfunction, has prompted the hypothesis that there is an association between mucosa-affecting diseases of the upper airways and the occurrence of cholesteatoma. The inconclusive findings of previous studies underscore the importance of the present investigation. This nationwide register study aimed to explore the association between mucosa-affecting diseases of the upper airways and cholesteatoma. This was done by studying chronic rhinosinusitis, nasal polyposis, allergy, adenoid hypertrophy, and tonsillar hypertrophy in individuals with cholesteatoma compared to matched controls. Additionally, the present study seeked to analyze the potential effects of age, sex, and family history cholesteatoma on this association.
Methods
Study design
This was a nationwide case–control study including all patients who underwent surgical treatment for cholesteatoma in Sweden between 1987 and 2018. The cases were retrieved from the National Patient Register, a nationwide register of discharge diagnoses and treatments with national coverage from inpatient care facilities since 1987. For diagnoses and treatments received at specialized outpatient care facilities, the register has national coverage from 2001. Diagnoses from general outpatients care facilities were not reported in the register during the study period [14].
The cases were identified using diagnostic codes, according to the International Classification of Diseases (ICD 9 and ICD 10), in combination with surgical codes according to the Swedish Classification of Medical Procedures and the 6th edition of Swedish Surgical Classification for cholesteatoma surgery registered at the same visit. Diagnostic codes are listed in Supplement 1. Two controls per case, matched for age, sex, and place of residency at the date of cholesteatoma surgery (hereinafter referred to as the index date), were obtained from the Total Population Register [15].
Exposure
Having a mucosa-affecting disease of the upper airways was defined as having one or more hospital visits for one of the following diagnoses: allergic rhinitis, chronic rhinitis, chronic sinusitis and/or nasal polyposis during any time between 1987 and 2018. For children < 15 years of age, having undergone adenoid, tonsillar or adenotonsillar surgery was also defined as having a mucosa-affecting disease of the upper airways. Both primary and secondary diagnoses were included and identified from the National Patient Register.
Other covariates
Demographic characteristics such as age, sex, and years registered as a Swedish resident were obtained from the Total Population Register. Family history of cholesteatoma was defined as having one or more first-degree relative who underwent cholesteatoma surgery between 1987 and 2018. Relatives of the cases and controls were identified in the Multigeneration Register. The patients with no known first-degree relative (n = 1308, 4.1%) were excluded from the subgroup analysis of family history to enhance the accuracy of the analyses.
Statistical analysis
Differences in categorical variables between cholesteatoma patients and controls, including family history of cholesteatoma and the presence of mucosa-affecting diseases of the upper airways, were analyzed using a chi-square test. For the comparison of the number of years registered as living in Sweden, the median was chosen due to a skewed distribution. For a comparison of the medians, the independent samples median test was used. Differences in the number of comorbidity diagnoses between cases and controls were analyzed using an independent samples t test. The association between mucosa-affecting diseases of the upper airways and cholesteatoma was investigated by estimating odds ratios (OR) and corresponding 95% confidence intervals (CI) using conditional logistic regression. A P value of < 0.05 was considered statistically significant. Stratified analyses by age, sex, family history of cholesteatoma, and index date before or after the year of 2000 were performed to examine the association between mucosa-affecting diseases of the upper airways and cholesteatoma in these subgroups. A sensitivity analysis was conducted excluding upper airway diagnoses received in the period 1 year before and 1 year after the index date. This analysis was performed to examine whether the variation in the number of diagnoses could be attributed to cases receiving medical attention for their cholesteatoma.
Data from the national registers were received in April 2022 and data analysis was performed from March to May 2023. All data analysis was performed using IBM SPSS Statistics for Windows version 25 (IBM) and SAS statistical software, version 9.4 (SAS Institute Inc).
Results
A total of 10,618 patients were identified as surgically treated for cholesteatoma in Sweden between 1987 and 2018, and 21,235 matched controls were additionally included in the study. For one cholesteatoma case, there was only one matched control, resulting in one less person than expected in the control group. Of the participants in the study, 59.4% were male and 77.3% were over 15 years of age at the index date. The median number of years registered as living in Sweden was 32.0 years in both cases and controls (Table 1).
Mucosa-affecting diseases of the upper airways were more common in cholesteatoma patients compared to controls, as was having mucosa-affecting airway diagnoses of more than one kind. The mean number of mucosa-affecting diseases of the upper airways did not differ between the groups (Table 1).
There was an association between chronic rhinitis, chronic sinusitis and nasal polyposis and cholesteatoma. All three diagnoses were statistically significantly more common in patients treated for cholesteatoma compared to matched controls. Similar associations between mucosa-affecting diseases of the upper airways and cholesteatoma as in the main analyses were seen in individuals without a family history of cholesteatoma. However, the association could not be investigated among individuals with a family history of cholesteatoma. This was due to the small number of individuals with both a family history of cholesteatoma and a mucosa-affecting disease of the upper airways (Table 2).
In a sensitivity analysis excluding diagnoses received in the period 1 year before and 1 year after the index date, no statistically significant association between chronic sinusitis and cholesteatoma was seen for patients with the index year 1987–2000, nor in patients < 15 years of age. The results of all other analyses remained statistically significant and the effect estimates remained similar (Table 2, Supplement 2).
Adenoid and tonsil surgery were statistically significantly more common in cholesteatoma patients compared to in controls. Adenoid surgery had the strongest association with an OR of > 4 in all subgroups. The association was seen in all the subgroups, with a P < 0.001 in all adenoid and tonsil surgery, as well as in adenoid surgery and tonsil surgery separately (Table 3).
Discussion
This nationwide register study of cholesteatoma surgeries over a 30-year period showed a 1.5 to 2.5 times higher prevalence of chronic rhinitis, chronic sinusitis, and nasal polyposis in cholesteatoma patients compared to controls. An even stronger association was observed for adenoid and/or tonsil surgery where choelsteatoma patients operated before 15 years of age were more than four times more likely than controls to have undergone adenoid surgery.
Previous studies have reported conflicting results regarding the association of different types of mucosa-affecting diseases of the upper airways and cholesteatoma. Two studies have found a statistically significant association between CRS and cholesteatoma, with cholesteatoma being twice as common in patients with CRS [3, 10]. These findings align with the results in the present study. The factors linking CRS and cholesteatoma have been hypothesized to be obstruction of the Eustachian tube and similar biomolecular or cellular dysregulation [3]. Another study showed a significant association between CRS and COM, however no association between cholesteatoma and CRS was shown in contradiction to the present study [2].
Adenoid surgery has previously been shown to be associated with cholesteatoma, where the rate of cholesteatoma dropped following adenoid surgery in a population-based retrospective study [16]. However, in another study the association was not statistically significant [17]. Adenoid hypertrophy, the reason for adenoid surgery, is associated with recurrent infections and biofilm in the adenoid which has been shown to be more common if the patient also suffers from CRS [13]. Recurrent infections may also lead to otitis media with effusion (OME) which in turn may lead to a retraction of the ear drum and further possibly to cholesteatoma [18, 19]. However, caution is needed when interpreting the results since adenoid surgery sometimes is performed as treatment for eardrum retraction to prevent the formation of a cholesteatoma [16]. Ear drum retraction is not a common indication for tonsillectomy [20]. Therefore, the association between tonsillectomy and cholesteatoma is possibly related to factors in the mucous epithelium rather than to Eustachian tube obstruction or eardrum retraction. The immunological response in the mucosa seems to affect both the nose, the paranasal sinuses, the epipharynx, and the middle ear. This leads to a hypothesis that recurrent infections or biofilm may be the link between the mucosa-affecting diseases of the upper airways and cholesteatoma.
CRS is a heterogenous disease where different inflammatory pathways are involved within the subgroups with and without nasal polyposis, and there has been extensive work on characterizing the immune response in CRS [21]. In the present study, CRS was divided into chronic rhinitis and chronic sinusitis separately, and the term nasal polyposis did not include rhinosinusitis. This was due to the use of ICD diagnostic codes in the National Patient Register. The results of the present study showed that both CRS with and without nasal polyposis were associated with cholesteatoma. This is supported by a cross-sectional study where cholesteatoma was associated with nasal polyposis and postnasal drip, a sign of CRS [11]. Since CRS is a heterogenous disease, there may be variants of the disease that have a stronger correlation with cholesteatoma, something that was not possible to investigate in the present study. Previous studies of nasal polyps have shown that healthy tissue adjacent to the polyps share characteristics with the polyps on a molecular level [22]. In cholesteatoma adjacent tissue dysregulation of a pathway of cell growth and inflammation has been shown [23]. Perhaps there are changes in cholesteatoma adjacent tissue caused by mucosa-affecting diseases of the upper airways.
Allergy differs from the other mucosa-affecting upper airway diagnoses in terms of its non-infectious and seasonal and mixed seasonal-perennial nature [24], which could explain the lack of association in the present study. Previous studies show conflicting results regarding the association between allergic rhinitis and cholesteatoma [11, 12, 25, 26]. Allergies are triggered by the exposure to environmental allergens, resulting in an IgE-mediated response that activates various cytokines and chemokines [27]. This indicate that IgE may not be the main pathway associated with cholesteatoma development. Supporting this is the lack of efficacy of antihistamines as treatment for OME [18]. However, the present study did not permit evaluation of the subgroups of CRS where some include elevated levels of IgE [28]. Therefore, inference on the association between IgE-mediated inflammation and cholesteatoma could not be made in the present study. Future studies of the subgroups of CRS are warranted to better understand the underlying mechanisms of the association with cholesteatoma.
Strengths and limitations
The use of data from the National Patient Register with national coverage of diagnoses provided objectively reported data for both cases and population-based controls. More cholesteatoma patients received upper airway diagnoses from different groups compared to controls. This could indicate that receiving medical attention for cholesteatoma leads to the identification of additional diagnoses. However, there was no statistically significant difference in the number of upper airway diagnoses between cases and controls. Furthermore, the sensitivity analysis where we excluded diagnoses received one year before or after the cholesteatoma surgery to account for increased surveillance of cholesteatoma patients, yield similar findings as the main analysis. This supports the association between mucosa-affecting diseases of the upper airways and cholesteatoma.
While the study provided valuable insights into the association between mucosa-affecting diseases of the upper airways and cholesteatoma, the findings may not be generalizable to other populations or healthcare systems. Another limitation is that changes in diagnostic criteria over time might have affected the results. There could also be a risk of faulty coding in both diagnostic and surgical codes. However, the register has a high sensitivity regarding surgical procedures [14]. In the present study only one surgical code for tonsillotomy was used. A more unspecific surgical code can be used but was not included in the present study which may have affected the results. However, this surgical code was omitted in both cases and controls and it has been decreasing in use since 2010 [29]. Furthermore, the design of the present study did not permit inference on the causality between mucosa-affecting diseases of the upper airways and cholesteatoma.
Conclusions
In this nationwide case–control study of cholesteatoma surgeries over a 30-year period a higher occurrence of chronic rhinitis, chronic sinusitis, and nasal polyposis was seen in cholesteatoma patients compared to controls. An even stronger association was observed for adenoid and/or tonsil surgery where an the strongest association was seen for adenoid surgery in individuals < 15 years of age. Further research is warranted to better understand the mechanisms of the association between mucosa-affecting diseases of the upper airways and cholesteatoma in regard to genetic, inflammatory and mucosal properties.
Data availability
These data are available for research purposes through applications to each register holder after ethical review and secrecy assessment. Data is available from Statistics Sweden (https://www.scb.se/vara-tjanster/bestalla-mikrodata/), the Swedish National Board of Health and Welfare (https://bestalladata.socialstyrelsen.se/data-for-forskning/) after ethical approval.
References
Massa HM, Lim DJ, Kurono Y, Cripps AW (2015) Middle ear and Eustachian tube mucosal immunology. In: Mestecky J, Strober W, Russell MW, Kelsall BL, Cheroutre H, Lambrecht BN (eds) Mucosal immunology, vol 101. Academic Press, Cambridge, pp 1923–1942
Hong SN, Lee WH, Lee SH, Rhee CS, Lee CH, Kim JW (2017) Chronic rhinosinusitis with nasal polyps is associated with chronic otitis media in the elderly. Eur Arch Otorhinolaryngol 274(3):1463–1470. https://doi.org/10.1007/s00405-016-4363-0
Kuo CL, Yen YC, Chang WP, Shiao AS (2017) Association between middle ear cholesteatoma and chronic rhinosinusitis. JAMA Otolaryngol Head Neck Surg 143(8):757–763. https://doi.org/10.1001/jamaoto.2017.0130
Juszczak HM, Loftus PA (2020) Role of allergy in Eustachian tube dysfunction. Curr Allergy Asthma Rep 20(10):54. https://doi.org/10.1007/s11882-020-00951-3
Yung M et al (2017) EAONO/JOS joint consensus statements on the definitions, classification and staging of middle ear cholesteatoma. J Int Adv Otol 13(1):1–8. https://doi.org/10.5152/iao.2017.3363
Kuo CL et al (2015) Updates and knowledge gaps in cholesteatoma research. Biomed Res Int 2015:854024. https://doi.org/10.1155/2015/854024
Castle JT (2018) Cholesteatoma pearls: practical points and update. Head Neck Pathol 12(3):419–429. https://doi.org/10.1007/s12105-018-0915-5
Kuo CL (2015) Etiopathogenesis of acquired cholesteatoma: prominent theories and recent advances in biomolecular research. Laryngoscope 125(1):234–240. https://doi.org/10.1002/lary.24890
Preciado DA (2012) Biology of cholesteatoma: special considerations in pediatric patients. Int J Pediatr Otorhinolaryngol 76(3):319–321. https://doi.org/10.1016/j.ijporl.2011.12.014
Son DS, Cho MS, Kim DK (2023) Chronic rhinosinusitis could increase the risk of cholesteatoma of middle ear. Int Forum Allergy Rhinol 13(2):168–171. https://doi.org/10.1002/alr.23065
Heo KW, Kim MJ, Lee JH (2018) Impact of nasal conditions on chronic otitis media: a cross-sectional study in Koreans. Acta Otolaryngol 138(2):116–121. https://doi.org/10.1080/00016489.2017.1385848
Tange RA, Grolman W, Woutersen DP (2000) The prevalence of allergy in young children with an acquired cholesteatoma. Auris Nasus Larynx 27(2):113–116. https://doi.org/10.1016/s0385-8146(99)00059-0
Niedzielski A, Chmielik LP, Mielnik-Niedzielska G, Kasprzyk A, Bogusławska J (2023) Adenoid hypertrophy in children: a narrative review of pathogenesis and clinical relevance. BMJ Paediatr Open. https://doi.org/10.1136/bmjpo-2022-001710
Ludvigsson JF et al (2011) External review and validation of the Swedish national inpatient register. BMC Public Health 11:450. https://doi.org/10.1186/1471-2458-11-450
Ludvigsson JF et al (2016) Registers of the Swedish total population and their use in medical research. Eur J Epidemiol 31(2):125–136. https://doi.org/10.1007/s10654-016-0117-y
Spilsbury K, Miller I, Semmens JB, Lannigan FJ (2010) Factors associated with developing cholesteatoma: a study of 45,980 children with middle ear disease. Laryngoscope 120(3):625–630. https://doi.org/10.1002/lary.20765
Djurhuus BD, Christensen K, Skytthe A, Faber CE (2015) The impact of ventilation tubes in otitis media on the risk of cholesteatoma on a national level. Int J Pediatr Otorhinolaryngol 79(4):605–609. https://doi.org/10.1016/j.ijporl.2015.02.005
Griffin G, Flynn CA (2011) Antihistamines and/or decongestants for otitis media with effusion (OME) in children. Cochrane Database Syst Rev 2011(9):CD003423. https://doi.org/10.1002/14651858.CD003423.pub3
Kemppainen HO, Puhakka HJ, Laippala PJ, Sipilä MM, Manninen MP, Karma PH (1999) Epidemiology and aetiology of middle ear cholesteatoma. Acta Otolaryngol 119(5):568–572. https://doi.org/10.1080/00016489950180801
Randall DA (2020) Current indications for tonsillectomy and adenoidectomy. J Am Board Fam Med 33(6):1025–1030. https://doi.org/10.3122/jabfm.2020.06.200038
Ahern S, Cervin A (2019) Inflammation and endotyping in chronic rhinosinusitis-a paradigm shift. Medicina. https://doi.org/10.3390/medicina55040095
Drakskog C, de Klerk N, Westerberg J, Mäki-Torkko E, Georén SK, Cardell LO (2020) Extensive qPCR analysis reveals altered gene expression in middle ear mucosa from cholesteatoma patients. PLoS ONE 15(9):e0239161. https://doi.org/10.1371/journal.pone.0239161
Westerberg J et al (2021) JAK/STAT dysregulation with SOCS1 overexpression in acquired cholesteatoma-adjacent mucosa. Otol Neurotol 42(1):e94–e100. https://doi.org/10.1097/MAO.0000000000002850
Skoner DP (2001) Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis. J Allergy Clin Immunol 108(1 Suppl):S2-8. https://doi.org/10.1067/mai.2001.115569
Kuo CL, Shiao AS, Wen HC, Chang WP (2018) Increased risk of cholesteatoma among patients with allergic rhinitis: a nationwide investigation. Laryngoscope 128(3):547–553. https://doi.org/10.1002/lary.26220
Hong SD, Cho YS, Hong SH, Chung WH, Chung KW (2008) Chronic otitis media and immunoglobulin E-mediated hypersensitivity in adults: is it a contributor of cholesteatoma? Otolaryngol Head Neck Surg 138(5):637–640. https://doi.org/10.1016/j.otohns.2007.12.037
Eifan AO, Durham SR (2016) Pathogenesis of rhinitis. Clin Exp Allergy 46(9):1139–1151. https://doi.org/10.1111/cea.12780
Fokkens WJ et al (2020) European position paper on rhinosinusitis and nasal polyps 2020. Rhinology 58(S29):1–464. https://doi.org/10.4193/Rhin20.600
Socialstyrelsen. www.socialstyrelsen.se/Statistik/statistikdatabas. Accessed 15 May 2023
Funding
Open access funding provided by Karolinska Institute. Grants from The Center for Innovative Medicine (FoUI-975599), ALF (FoUI-955027), the re(HFF19-0016) and ACTA Otolaryngologica.
Author information
Authors and Affiliations
Contributions
All authors contributed to conceptualization and design. Data collection and analysis was performed by Agnes Modée Borgström, Åsa Bonnard and Hanna Mogensen. The first draft of the text was written by Agnes Modée Borgström and all authors contributed to critical revisioning of the manuscript. All authors approved of the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflicts of interest to declare.
Ethical approval
The study has been approved by The Swedish Ethical Review Authority (2019-05190, 2020-000245, 2021-05727-02), and informed consent was waived due to the large sample size and the use of register data. The study follows the Strengthening of the Reporting of Observational Studies in Epidemiology (STROBE) reporting guideline.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Modée Borgström, A., Mogensen, H., Engmér Berglin, C. et al. Occurrence of mucosa-affecting diseases of the upper airways in middle ear cholesteatoma patients: a nationwide case–control study. Eur Arch Otorhinolaryngol 281, 4081–4087 (2024). https://doi.org/10.1007/s00405-024-08567-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-024-08567-3